EryDex Low dose DSP
IEDAT-02-2015
Phase 3 small_molecule completed
Quick answer
EryDex Low dose DSP for Nervous System Disease is a Phase 3 program (small_molecule) at Quince Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Quince Therapeutics
- Indication
- Nervous System Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed